Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain bleed drug under the microscope: does it really shrink bleeding?

NCT ID NCT05127941

First seen May 12, 2026 · Last updated May 21, 2026 · Updated 3 times

Summary

This study followed 141 people in German stroke units who had a brain bleed while taking the blood thinners rivaroxaban or apixaban. Researchers observed whether giving the reversal drug andexanet alfa reduced the size of the bleed. The goal was to gather real-world data, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL HEMORRHAGES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Medizinische Hochschule Hannover

    Hanover, 30625, Germany

  • Universitätsklinikum Tübingen

    Tübingen, 72076, Germany

Conditions

Explore the condition pages connected to this study.